<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lin CY</submitter><funding>Ministry of Science and Technology, Taiwan</funding><funding>Chang Gung Medical Foundation</funding><pagination>11020</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8539319</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(20)</volume><pubmed_abstract>The α7-human papillomavirus (HPV)-related cervical squamous cell carcinoma (SCC) is associated with poor prognosis. We compared the genomic profiles of this disease in a cohort corresponding to the 2001-2014 period with various responses to radiotherapy or concurrent chemoradiation through microRNA (miR) profiling involving miR 4.0 array and human transcriptome array 2.0 analyses. A real-time quantitative polymerase chain reaction was then conducted to identify the predictive biomarkers. A significantly lower expression of miR143-3p in recurrent tumors (p = 0.0309) relative to that in nonrecurrent tumors was observed. The miR143-3p targeted the mRNA expression of the baculoviral inhibitor of the apoptosis protein (IAP) repeat-containing 2 (BIRC2; p = 0.0261). The BIRC2 protein levels (p = </pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Inhibition of BIRC2 Sensitizes α7-HPV-Related Cervical Squamous Cell Carcinoma to Chemotherapy.</pubmed_title><pmcid>PMC8539319</pmcid><funding_grant_id>CMRPG3F2241-3</funding_grant_id><funding_grant_id>MOST 104-2314-B-182-047-MY3</funding_grant_id><pubmed_authors>Chang CB</pubmed_authors><pubmed_authors>Pan YB</pubmed_authors><pubmed_authors>Yang LY</pubmed_authors><pubmed_authors>Lai CH</pubmed_authors><pubmed_authors>Wang CC</pubmed_authors><pubmed_authors>Wu RC</pubmed_authors><pubmed_authors>Lin CY</pubmed_authors><pubmed_authors>Chao A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Inhibition of BIRC2 Sensitizes α7-HPV-Related Cervical Squamous Cell Carcinoma to Chemotherapy.</name><description>The α7-human papillomavirus (HPV)-related cervical squamous cell carcinoma (SCC) is associated with poor prognosis. We compared the genomic profiles of this disease in a cohort corresponding to the 2001-2014 period with various responses to radiotherapy or concurrent chemoradiation through microRNA (miR) profiling involving miR 4.0 array and human transcriptome array 2.0 analyses. A real-time quantitative polymerase chain reaction was then conducted to identify the predictive biomarkers. A significantly lower expression of miR143-3p in recurrent tumors (p = 0.0309) relative to that in nonrecurrent tumors was observed. The miR143-3p targeted the mRNA expression of the baculoviral inhibitor of the apoptosis protein (IAP) repeat-containing 2 (BIRC2; p = 0.0261). The BIRC2 protein levels (p = </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2025-04-19T15:09:16.471Z</modification><creation>2025-04-19T15:09:16.471Z</creation></dates><accession>S-EPMC8539319</accession><cross_references><pubmed>34681681</pubmed><doi>10.3390/ijms222011020</doi></cross_references></HashMap>